These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
394 related articles for article (PubMed ID: 27713269)
1. Platelet-Derived Growth Factor (PDGF)/PDGF Receptors (PDGFR) Axis as Target for Antitumor and Antiangiogenic Therapy. Raica M; Cimpean AM Pharmaceuticals (Basel); 2010 Mar; 3(3):572-599. PubMed ID: 27713269 [TBL] [Abstract][Full Text] [Related]
2. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor. Zhao Y; Adjei AA Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391 [TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic and antitumor activity of a selective PDGFR tyrosine kinase inhibitor, CP-673,451. Roberts WG; Whalen PM; Soderstrom E; Moraski G; Lyssikatos JP; Wang HF; Cooper B; Baker DA; Savage D; Dalvie D; Atherton JA; Ralston S; Szewc R; Kath JC; Lin J; Soderstrom C; Tkalcevic G; Cohen BD; Pollack V; Barth W; Hungerford W; Ung E Cancer Res; 2005 Feb; 65(3):957-66. PubMed ID: 15705896 [TBL] [Abstract][Full Text] [Related]
4. Identification of a subset of pericytes that respond to combination therapy targeting PDGF and VEGF signaling. Hasumi Y; Kłosowska-Wardega A; Furuhashi M; Ostman A; Heldin CH; Hellberg C Int J Cancer; 2007 Dec; 121(12):2606-14. PubMed ID: 17691110 [TBL] [Abstract][Full Text] [Related]
5. Differential roles of PDGFR-alpha and PDGFR-beta in angiogenesis and vessel stability. Zhang J; Cao R; Zhang Y; Jia T; Cao Y; Wahlberg E FASEB J; 2009 Jan; 23(1):153-63. PubMed ID: 18827023 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of protein kinase C enhances angiogenesis induced by platelet-derived growth factor C in hyperglycemic endothelial cells. Moriya J; Ferrara N Cardiovasc Diabetol; 2015 Feb; 14():19. PubMed ID: 25849290 [TBL] [Abstract][Full Text] [Related]
7. The antiangiogenic agents SU5416 and SU6668 increase the antitumor effects of fractionated irradiation. Ning S; Laird D; Cherrington JM; Knox SJ Radiat Res; 2002 Jan; 157(1):45-51. PubMed ID: 11754641 [TBL] [Abstract][Full Text] [Related]
8. VEGF-A/VEGFR-2 and FGF-2/FGFR-1 but not PDGF-BB/PDGFR-β play important roles in promoting immature and inflammatory intraplaque angiogenesis. Mao Y; Liu X; Song Y; Zhai C; Zhang L PLoS One; 2018; 13(8):e0201395. PubMed ID: 30125282 [TBL] [Abstract][Full Text] [Related]
9. Time- and cell type-specific induction of platelet-derived growth factor receptor-beta during cerebral ischemia. Renner O; Tsimpas A; Kostin S; Valable S; Petit E; Schaper W; Marti HH Brain Res Mol Brain Res; 2003 May; 113(1-2):44-51. PubMed ID: 12750005 [TBL] [Abstract][Full Text] [Related]
10. Chemosensitization by STI571 targeting the platelet-derived growth factor/platelet-derived growth factor receptor-signaling pathway in the tumor progression and angiogenesis of gastric carcinoma. Kim R; Emi M; Arihiro K; Tanabe K; Uchida Y; Toge T Cancer; 2005 May; 103(9):1800-9. PubMed ID: 15786421 [TBL] [Abstract][Full Text] [Related]
12. Predicting Effectiveness of Imatinib Mesylate in Tumors Expressing Platelet-Derived Growth Factors (PDGF-AA, PDGF-BB), Stem Cell Factor Ligands and Their Respective Receptors (PDGFR-α, PDGFR-β, and c-kit). Moawad EY J Gastrointest Cancer; 2015 Sep; 46(3):272-83. PubMed ID: 25985771 [TBL] [Abstract][Full Text] [Related]
13. The selective class III/V receptor tyrosine kinase inhibitor SU11657 inhibits tumor growth and angiogenesis in experimental neuroblastomas grown in mice. Bäckman U; Christofferson R Pediatr Res; 2005 May; 57(5 Pt 1):690-5. PubMed ID: 15718357 [TBL] [Abstract][Full Text] [Related]
14. Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-alphaalpha and -alphabeta receptors. Cao R; Bråkenhielm E; Li X; Pietras K; Widenfalk J; Ostman A; Eriksson U; Cao Y FASEB J; 2002 Oct; 16(12):1575-83. PubMed ID: 12374780 [TBL] [Abstract][Full Text] [Related]